Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging

NCT03078192 is registered in ClinicalTrials.gov with Bastiaan Driehuys as lead sponsor.

NCT NCT03078192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03078192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging
Lead sponsor
Bastiaan Driehuys
Phase
Phase 2
Overall status
Completed
Start date
May 3, 2017
Completion date
October 22, 2020
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary vascular disease